Oncotelic Therapeutics, Inc. Quarterly Return On Assets in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Oncotelic Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from Q1 2012 to Q3 2024.
  • Oncotelic Therapeutics, Inc. Return On Assets for the quarter ending September 30, 2024 was -16 %, a 57.6% increase year-over-year.
  • Oncotelic Therapeutics, Inc. annual Return On Assets for 2023 was -25.1 %, a 272% decline from 2022.
  • Oncotelic Therapeutics, Inc. annual Return On Assets for 2022 was 14.6 %.
  • Oncotelic Therapeutics, Inc. annual Return On Assets for 2021 was -39.8 %, a 0.3% decline from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -16 +21.7 +57.6% Jul 1, 2024 Sep 30, 2024
Q2 2024 -4.13 +33.4 +89% Apr 1, 2024 Jun 30, 2024
Q1 2024 -25.9 -50.6 -205% Jan 1, 2024 Mar 31, 2024
Q4 2023 -25.1 -39.6 -272% Oct 1, 2023 Dec 31, 2023
Q3 2023 -37.7 -64.7 -240% Jul 1, 2023 Sep 30, 2023
Q2 2023 -37.5 -65.8 -233% Apr 1, 2023 Jun 30, 2023
Q1 2023 24.7 +73.5 Jan 1, 2023 Mar 31, 2023
Q4 2022 14.6 +54.3 Oct 1, 2022 Dec 31, 2022
Q3 2022 27 +73.7 Jul 1, 2022 Sep 30, 2022
Q2 2022 28.3 +76.1 Apr 1, 2022 Jun 30, 2022
Q1 2022 -48.9 -17.1 -53.8% Jan 1, 2022 Mar 31, 2022
Q4 2021 -39.8 -0.12 -0.3% Oct 1, 2021 Dec 31, 2021
Q3 2021 -46.7 -6.89 -17.3% Jul 1, 2021 Sep 30, 2021
Q2 2021 -47.8 -4.38 -10.1% Apr 1, 2021 Jun 30, 2021
Q1 2021 -31.8 +34.3 +51.9% Jan 1, 2021 Mar 31, 2021
Q4 2020 -39.6 +28 +41.4% Oct 1, 2020 Dec 31, 2020
Q3 2020 -39.8 +32.5 +44.9% Jul 1, 2020 Sep 30, 2020
Q2 2020 -43.4 +41.5 +48.9% Apr 1, 2020 Jun 30, 2020
Q1 2020 -66.1 +27.7 +29.6% Jan 1, 2020 Mar 31, 2020
Q4 2019 -67.6 -23.3 -52.6% Oct 1, 2019 Dec 31, 2019
Q3 2019 -72.3 +174 +70.7% Jul 1, 2019 Sep 30, 2019
Q2 2019 -84.8 +293 +77.6% Apr 1, 2019 Jun 30, 2019
Q1 2019 -93.8 +268 +74.1% Jan 1, 2019 Mar 31, 2019
Q4 2018 -44.3 +221 +83.3% Oct 1, 2018 Dec 31, 2018
Q3 2018 -246 -70.9 -40.4% Jul 1, 2018 Sep 30, 2018
Q2 2018 -378 -257 -213% Apr 1, 2018 Jun 30, 2018
Q1 2018 -362 -269 -292% Jan 1, 2018 Mar 31, 2018
Q4 2017 -265 -193 -269% Oct 1, 2017 Dec 31, 2017
Q3 2017 -176 -112 -177% Jul 1, 2017 Sep 30, 2017
Q2 2017 -121 -64.4 -114% Apr 1, 2017 Jun 30, 2017
Q1 2017 -92.2 -43.3 -88.3% Jan 1, 2017 Mar 31, 2017
Q4 2016 -71.8 -29.3 -68.8% Oct 1, 2016 Dec 31, 2016
Q3 2016 -63.4 -25.9 -68.9% Jul 1, 2016 Sep 30, 2016
Q2 2016 -56.5 -20.1 -55.2% Apr 1, 2016 Jun 30, 2016
Q1 2016 -49 -11.6 -31.2% Jan 1, 2016 Mar 31, 2016
Q4 2015 -42.5 -2.32 -5.77% Oct 1, 2015 Dec 31, 2015
Q3 2015 -37.5 +9.64 +20.4% Jul 1, 2015 Sep 30, 2015
Q2 2015 -36.4 +21.1 +36.7% Apr 1, 2015 Jun 30, 2015
Q1 2015 -37.3 +34.8 +48.3% Jan 1, 2015 Mar 31, 2015
Q4 2014 -40.2 +70.1 +63.6% Oct 1, 2014 Dec 31, 2014
Q3 2014 -47.2 +64.4 +57.7% Jul 1, 2014 Sep 30, 2014
Q2 2014 -57.5 +58.1 +50.2% Apr 1, 2014 Jun 30, 2014
Q1 2014 -72.1 +55.8 +43.6% Jan 1, 2014 Mar 31, 2014
Q4 2013 -110 +0.94 +0.85% Oct 1, 2013 Dec 31, 2013
Q3 2013 -112 -10.6 -10.5% Jul 1, 2013 Sep 30, 2013
Q2 2013 -116 -18.3 -18.7% Apr 1, 2013 Jun 30, 2013
Q1 2013 -128 -28.3 -28.4% Jan 1, 2013 Mar 31, 2013
Q4 2012 -111 Oct 1, 2012 Dec 31, 2012
Q3 2012 -101 Jul 1, 2012 Sep 30, 2012
Q2 2012 -97.3 Apr 1, 2012 Jun 30, 2012
Q1 2012 -99.6 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.